Saturday, 31 October 2026 NSE & BSE filings, as they land
ALFA News Straight from the exchange filing
Product Launched

Tata Elxsi Launches ViTel AI-Powered Med-Tech Solution to Streamline Compliance

Tata Elxsi has introduced ViTel™, a specialized material intelligence solution designed for medical device manufacturers. Developed in partnership with Viridium AI, the tool utilizes science-constrained AI models to automate material risk assessment and regulatory compliance across the product lifecycle.

A collection of medical supplies including pills, a mask, and a thermometer on a blue surface. Stock photo illustrating Tata Elxsi's product launched story.
Photo: Marta Branco / Pexels
Key numbers
Market Cap ₹26,992.71 CrCap size
Revenue TTM ₹3,757.42 CrOperating
Net Profit Growth 27.8%Quarterly YoY
RSI 55.66Neutral Zone

Key highlights

  • Launch of ViTel™, a Material Intelligence layer for the Med-Tech enterprise
  • Co-developed with Viridium AI through Tata Elxsi’s STEP UP co-innovation program
  • Integration of Viridium AI’s Knowledge Cloud and Chemical Digital Twin technology
  • Designed to identify material dependencies, sourcing exposure, and regulatory risks
  • Formal introduction scheduled for the DeviceTalks Boston 2026 conference

The Product — What It Is

  • AI-powered platform transforming enterprise data into a living product-material knowledge graph
  • Connects chemicals, suppliers, parts, and regulations to provide evidence-based insights
  • Employs science-constrained AI models to reason about material risk and sourcing decisions
  • Addresses critical product knowledge buried in Bills of Materials and ERP systems
  • Provides a reusable Material Intelligence layer to evaluate country-of-origin exposure

Commercial Opportunity

Medical device manufacturers currently face significant margin pressures and complex regulatory environments where manual material assessment is costly. ViTel targets a growing market for automated compliance solutions, aiming to reduce the overhead of managing diverse supplier networks and evolving global standards. By digitizing material DNA, the solution allows manufacturers to protect margins and accelerate product velocity.

The collaboration leverages Tata Elxsi's access to global healthcare enterprises, positioning the product as a critical infrastructure tool for high-stakes Med-Tech engineering and quality assurance workflows.

Tata Elxsi · share price, past month

Strategic Fit

This launch aligns with Tata Elxsi’s design-led and AI-first engineering strategy, particularly within its Healthcare and Life Sciences division. The division is ISO 13485 certified, reflecting a deep commitment to medical industry standards. ViTel is the latest output of the STEP UP program, which focuses on co-innovation with deep-tech companies like Viridium AI.

By embedding three decades of regulatory expertise into the AI's reasoning engine, Tata Elxsi transitions from traditional service delivery to providing high-value, platform-based intelligence that solves recurring industry bottlenecks in product engineering.

Financial Context

Tata Elxsi maintains a robust financial profile with a TTM revenue of 3,757.42 crore and a net profit of 628.43 crore. While annual profit growth saw a 19.94 percent decline, quarterly performance has shown resilience with a 27.8 percent increase in net profit. The company operates with a high operating profit margin of 24.61 percent at the quarterly level.

This new product launch represents a move towards higher-margin, IP-led revenue streams within its IT Consulting and Software segment, potentially offsetting sector-wide volatility and diversifying its service portfolio beyond traditional offshore engineering services.

“ViTel™ brings Material Intelligence directly into the product and compliance workflows that matter most, helping our customers make faster, more confident decisions across sourcing, engineering, quality, and regulatory readiness.”

— Sreevatsa Sahasranaman, Senior Vice President and Head, Healthcare and Life Sciences, Tata Elxsi

“Viridium AI was built to help manufacturers understand the material DNA of their products. In Med-Tech, that intelligence creates a strategic foundation for the manufacturer.”

— Niraj Deo, Chief Executive Officer, Viridium AI

“The question that led to ViTel™ was a simple one: what could the world's best material intelligence capability become if it truly understood healthcare?”

— Muthusamy Selvaraj, VP, Innovation and Partnerships, Healthcare and Life Sciences, Tata Elxsi
Tata Elxsi · financial snapshot
Share price₹4332.9
Market capitalisation₹26,992.71 Cr
Revenue (annual)₹3,757.42 Cr
Net profit (annual)₹628.43 Cr
Revenue (latest quarter)₹993.75 Cr+4.22% vs previous quarter
Net profit (latest quarter)₹220.35 Cr+102.36% vs previous quarter
P/E (TTM)42.95×Sector 21.74×
Promoter holding43.9%0.00% QoQ
FII holding11.08%Current quarter

Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.

Source verified

Exchange filing by Tata Elxsi Limited announcing the launch of ViTel™, a Material Intelligence solution for Med-Tech. Market figures from a third-party data provider.

Read the filing ↗
All Tata Elxsi filings and newsView all → Every Tata Elxsi announcement on ALFA FilingsSee filings →

More from Tata Elxsi

All →

More in Launches

All →